Login Contact Us
Jul 2017, Vol 5, Issue 3
Advanced Search
How do you find the scientific quality of the published articles on our web site?
Polycystic Ovary Syndrome is Affected and Protected by DD and DI Genotypes of Angiotensin Converting Enzyme, Respectively: An Update of a Meta-Analysis
Fatemeh Yari1, Kamran Aeinfar2, Saber Abbaszadeh3, Khatereh Anbari4, Seyyed Amir Yasin Ahmadi3
1Depatment of Reproductive Health, Lorestan University of Medical Sciences, Khorramabad, Iran
2Rajaei Cardiovascular, Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran
3Student Research Committee, Lorestan University of Medical Sciences, Khorramabad, Iran
4Department of Community Medicine, Lorestan University of Medical Sciences, Khorramabad, Iran

IJWHR 2017; 5: 164?170
DOI: 10.15296/ijwhr.2017.30
Viewed : 3733 times
Downloaded : 2907 times.

Keywords : Angiotensin converting enzyme inhibitors, Meta-analysis, Polycystic ovary syndrome
Full Text(PDF) | Related Articles
Objectives: Angiotensin converting enzyme (ACE) is an important enzyme involved in the physiopathology of renal, cardiovascular and ovarian systems. One of these ACE related diseases is polycystic ovary syndrome (PCOS).

Materials and Methods: We intend to update the only meta-analysis written by Jia et al in 2013 on the association of ACE gene polymorphism and risk of PCOS. The reason of our attempt to update this meta-analysis was that they found no significant relation in their meta-analysis. For this aim, we searched in databases for relevant documents.

Results: We found 8 relevant papers, 6 of which had been covered by Jia et al meta-analysis. In order to perform this meta-analysis, we used comprehensive meta-analysis software. The analysis was done through P value and sample size of each study based on fixed-effect model. Analyses were performed in 5 different groups of alleles and genotypes. Among these 5 analyses, 4 of them were statistically significant. Hereby, we concluded that DD genotype of ACE is a risk factor for PCOS (P value = 0.013; odds ratio [OR] = 1.195), while DI is the protecting genotype (P = 0.009; OR = 0.819).

Conclusion: Hence, it is suggested to use a very low dose of captopril as an ACE inhibitor in the PCOS patients having DD genotype in future as a clinical trial, just as a scientific model. Further investigation on ovary ACE system is needed.

Cite By, Google Scholar

Google Scholar

Articles by Yari F
Articles by Aeinfar K
Articles by Abbaszadeh S
Articles by Anbari K


Articles by Fatemeh Yari
Articles by Kamran Aeinfar
Articles by Saber Abbaszadeh
Articles by Khatereh Anbari

Submit Paper
Online Submission System
IJWHR ENDNOTE ® Style Tutorials Publication Charge Women's Reproductive Health Research Center About Journal
Publication Information
Published Article Statistics